Categories AlphaGraphs, Earnings, Health Care
Key highlights from Biogen’s (BIIB) Q3 2024 earnings results
Biogen Inc. (NASDAQ: BIIB) reported its third quarter 2024 earnings results today.
Total revenue decreased 3% year-over-year to $2.46 billion. Revenues were down 3% on a constant currency basis as well.
Net income attributable to Biogen Inc. was $388.5 million, or $2.66 per share, compared to a loss of $68.1 million, or $0.47 per share, last year. Adjusted EPS decreased 6% to $4.08.
For the full year of 2024, Biogen expects total revenue to decline by a low-single-digit percentage compared to the previous year. Adjusted EPS is expected to be $16.10-16.60.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
CCL Earnings: Carnival Corp. Q4 2024 revenue rises 10%
Carnival Corporation & plc. (NYSE: CCL) Friday reported strong revenue growth for the fourth quarter of 2024. The cruise line operator reported a profit for Q4, compared to a loss
Key metrics from Nike’s (NKE) Q2 2025 earnings results
NIKE, Inc. (NYSE: NKE) reported total revenues of $12.4 billion for the second quarter of 2025, down 8% on a reported basis and down 9% on a currency-neutral basis. Net
FDX Earnings: FedEx Q2 2025 adjusted profit increases; revenue dips
Cargo giant FedEx Corporation (NYSE: FDX), which completed an organizational restructuring recently, announced financial results for the second quarter of 2025. Second-quarter earnings, excluding one-off items, were $4.05 per share,
